Jennifer Doudna Headshot
Report a problem with this profile
[email protected]

Jennifer Doudna  

Technology Co-Inventor of CRISPR- Cas9

As an internationally renowned professor of Chemistry and Molecular and Cell Biology at U.C. Berkeley, Jennifer Doudna and her colleagues rocked the research world in 2012 by describing a simple way of editing the DNA of any organism using an RNA-guided protein found in bacteria. This technology, called CRISPR-Cas9, has opened the floodgates of possibility for human and non-human applications of gene editing, including assisting researchers in the fight against HIV, sickle cell disease and muscular dystrophy.

Doudna is an Investigator with the Howard Hughes Medical Institute and a member of the National Academy of Sciences, the National Academy of Medicine, the National Academy of Inventors and the American Academy of Arts and Sciences. She is also a Foreign Member of the Royal Society, and has received many other honors including the Breakthrough Prize in Life Sciences, the Heineken Prize, the BBVA Foundation Frontiers of Knowledge Award and the Japan Prize.

Doudna is the co-author with Sam Sternberg of “A Crack in Creation”, a personal account of her research and the societal and ethical implications of gene editing.

In 2020, she was awarded alongside Emmanuelle Charpentier with the Nobel Prize.


CRISPR creators, startup founders win Nobel Prize
Scientists and co-founders Emmanuelle Charpentier and Jennifer Doudna received the prestigious award Wednesday.
Jennifer Doudna Has Won A CRISPR Gene-Editing Patent
A biotech startup has been issued a patent that involves CRISPR, the breakthrough gene-editing method that has sparked a nearly unprecedented intellectual property feud between some of the country’s biggest institutions. But it’s unclear what effect, if any, the patent will have on that fight.
DNA-Editing Company Goes Public While Nasty Patent Fight Roars On
The Boston biotech Editas Medicine went public on Wednesday armed with unusually big ambitions and resources: It aims to cure genetic diseases with a hot and controversial technology, called CRISPR, which allows scientists to precisely “edit” DNA. Before going public, the company was backed by more than $160 million in private money from Bill Gates, Google Ventures, and more than a dozen other investors. But all of that now rests on a heated intellectual property feud between two renowned scientists, each of whom claim to have invented CRISPR. One is Jennifer Doudna at the University of California at Berkeley, the other Feng Zhang of the Broad Institute and the Massachusetts Institute of Technology. But they weren’t always rivals: They co-founded Editas in fall 2013.

Related Speakers View all

More like Jennifer